A Dose-Ranging Phase II Study of AUR101 in Psoriasis (INDUS-3)
Public ClinicalTrials.gov record NCT04855721. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Multicenter, Double-blind, Double-dummy, Placebo Controlled, Randomized Study to Evaluate the Efficacy and Safety of AUR101 in Patients With Moderate-to-Severe Psoriasis (INDUS-3)
Study identification
- NCT ID
- NCT04855721
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Aurigene Discovery Technologies Limited
- Industry
- Enrollment
- 141 participants
Conditions and interventions
Conditions
Interventions
- AUR101 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 3, 2021
- Primary completion
- Nov 29, 2022
- Completion
- Dec 9, 2022
- Last update posted
- Dec 12, 2022
2021 – 2022
United States locations
- U.S. sites
- 25
- U.S. states
- 9
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Johnson Dermatology | Fort Smith | Arkansas | 72916 | — |
| Northwest AR Clinical Trials Center | Rogers | Arkansas | 72758 | — |
| First OC Dermatology | Fountain Valley | California | 92708 | — |
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| University Clinical Trials, Inc. | San Diego | California | 92123 | — |
| Clinical Science Institute | Santa Monica | California | 90404 | — |
| Unison Clinical Trials | Sherman Oaks | California | 91403 | — |
| Moore Clinical Research, Inc. | Brandon | Florida | 33511 | — |
| Skin Research Institute | Coral Gables | Florida | 33146 | — |
| Accel Research Sites - Deland CRU | DeLand | Florida | 32720 | — |
| FXM Clinical Research Fort Lauderdale | Fort Lauderdale | Florida | 33308 | — |
| Direct Helpers Research Center | Hialeah | Florida | 33012 | — |
| Abys New Generation Research Inc. | Hialeah | Florida | 33016 | — |
| FXM Clinical Research Miami LLC | Miami | Florida | 33175 | — |
| Floridian Reserach | Miami | Florida | 33179 | — |
| FXM Clinical Research Miramar LLC | Miramar | Florida | 33027 | — |
| Lenus Research & Medical Group, LLC | Sweetwater | Florida | 33172 | — |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46250 | — |
| Great Lakes Research Group, Inc | Bay City | Michigan | 48706 | — |
| Medisearch Clinical Trials | Saint Joseph | Missouri | 64506 | — |
| The Dermatology Specialists | New York | New York | 10012 | — |
| Sadick Research Group | New York | New York | 10075 | — |
| Paddington Testing Co, Inc | Philadelphia | Pennsylvania | 19103 | — |
| Dermatology Treatment & Research Center | Dallas | Texas | 75230 | — |
| Center for Clinical Studies Ltd., LLP. | Webster | Texas | 77598 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04855721, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 12, 2022 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04855721 live on ClinicalTrials.gov.